Showing results (141-150 of 221) with videos related to
Sort By:
Pageof 23
The Lancet. Respiratory Medicine|February 3, 2025
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trialsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.Respiratory Medicine|March 2, 2025
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scoresClaus F Vogelmeier, Klaus F Rabe, Surya P Bhatt, et al.Journal of Computer Assisted Tomography|September 17, 2016
Arterial and Venous Pulmonary Vascular Morphology and Their Relationship to Findings in Cardiac Magnetic Resonance Imaging in SmokersFarbod N Rahaghi, J Michael Wells, Carolyn E Come, et al.Respiratory Medicine|October 31, 2024
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.JAMA|June 26, 2019
Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and MortalitySurya P Bhatt, Pallavi P Balte, Joseph E Schwartz, et al.The American Journal of Medicine|August 2, 2019
Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung StudyGeorge R Washko, Laura A Colangelo, Raul San José Estépar, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGene® CohortRachel N Criner, Wassim W Labaki, Elizabeth A Regan, et al.ERJ Open Research|November 17, 2018
Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary diseaseKatherine E Lowe, Barry J Make, James D Crapo, et al.Respiratory Medicine|February 24, 2022
Chronotropic index during 6-minute walk and acute respiratory events in COPDGeneDavid M Macdonald, Elise F Palzer, Asghar Abbasi, et al.The Lancet. Respiratory Medicine|September 14, 2014
Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational studySurya P Bhatt, James M Wells, Victor Kim, et al.Pageof 23